Hap Trading, LLC Xeris Biopharma Holdings, Inc. Call Options Transaction History

Hap Trading, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$1.14 - $1.65 $4,902 - $7,095	4,300 Added 13.15%	37,000 $0
Q3 2022 Nov 14, 2022	SELL	$1.37 - $1.93 $1,507 - $2,123	-1,100 Reduced 3.25%	32,700 $2,000
Q2 2022 Aug 12, 2022	SELL	$1.48 - $2.64 $10,919 - $19,477	-7,378 Reduced 17.92%	33,800 $6,000
Q1 2022 May 12, 2022	SELL	$2.0 - $2.87 $133,648 - $191,784	-66,824 Reduced 61.87%	41,178 $12,000
Q4 2021 Feb 14, 2022	BUY	$1.8 - $2.93 $194,403 - $316,445	108,002 New	108,002 $34,000

142

59.9M

148K

45.7K

Ticker XERS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,956,992
Market Cap $458M
Description
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.